other material
confidence high
sentiment neutral
materiality 0.55
Adaptive Biotechnologies subsidiary Digital Biotechnologies closes Series A up to $15M
Adaptive Biotechnologies Corp
- Digital Biotechnologies, 70%-owned subsidiary, held initial closing of Series A Preferred Stock financing.
- Anticipated total proceeds of up to $15 million from the Series A round.
- Upon completion, Adaptive expects to retain nearly 50% ownership and continue consolidating Digital's results.
- Digital Biotechnologies is an early-stage company with no revenues and limited activities to date.